Sample sizes for brain atrophy outcome measures in clinical trials for secondary progressive multiple sclerosis

D. R. Altmann; Bas Jasperse; Frederik Barkhof; K. Beckmann; Massimo Filippi; Ludwig Kappos; P. D. Molyneux; CH Polman; Carlo Pozzilli; Alan J. Thompson; K. Wagner; Tarek Yousry; D. H. Miller; Euspms Mri SubStudy

Related publications

Article2008

Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis

Daniel R. Altmann, Bas Jasperse, Frederik Barkhof, K. Beckmann, Massimo Filippi, L. D. Kappos, P. D. Molyneux, Chris H. Polman, Carlo Pozzilli, Alan J. Thompson, K. Wagner, Tarek Yousry, D. H. Miller

Article2017

Comparison of brain atrophy measures for clinical use in multiple sclerosis

Loredana Storelli, Maria A. Rocca, Elisabetta Pagani, W. van Hecke, Nicola De Stefano, Àlex Rovira, Jaume Sastre‐Garriga, Jackie Palace, Massimo Filippi

Article2014

Magnetic resonance outcome measures in multiple sclerosis trials

Massimo Filippi, Paolo Preziosa, Maria A. Rocca

Article2000

The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis

P. D. Molyneux, Ludwig Kappos, Chris H. Polman, Carlo Pozzilli, Frederik Barkhof, Massimo Filippi, Tarek Yousry, David W. Hahn, Klaus Wagner, Mahdiyeh Khabbaz Koche Ghazi, K. Beckmann, Frank Dahlke, Nicholas Losseff, Gareth J. Barker, Alan J. Thompson, D. H. Miller

Article2010

Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis

I.J. van den Elskamp, Barry P. Boden, Vincenzo Dattola, Dirk L. Knol, Massimo Filippi, Ludwig Kappos, Franz Fazekas, K. Wagner, Christoph Pohl, Rupert Sandbrink, Chris H. Polman, Bernard M.J. Uitdehaag, Frederik Barkhof